Cellosaurus MDA-MB-453 Ad15 (CVCL_ZZ23)
Cell line name | MDA-MB-453 Ad15 |
---|---|
Accession | CVCL_ZZ23 |
Resource Identification Initiative | To cite this cell line use: MDA-MB-453 Ad15 (RRID:CVCL_ZZ23) |
Comments | Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian. Doubling time: 120.5 hours (PubMed=9815641). Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409. |
Sequence variations |
|
Disease | Breast adenocarcinoma (NCIt: C5214) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0418 (MDA-MB-453) |
Sex of cell | Female |
Age at sampling | 48Y |
Category | Cancer cell line |
Publications | PubMed=9815641 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_ZZ23 |
Encyclopedic resources | Wikidata; Q102114522 |
Entry history | |
Entry creation | 29-Oct-2020 |
Last entry update | 05-Oct-2023 |
Version number | 7 |